Who Buys Erythromycin from India — 992 Importers Behind a $79.7M Market

The importers of Erythromycin from India can be categorized into several key segments:

1. Government Procurement Agencies: Entities like UNICEF Kabul in Afghanistan ($22.63M) and the Medical Stores Department in Tanzania ($1.14M) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply public health programs, ensuring consistent demand and sizable order volumes.

2. Pharmaceutical Distributors: Companies such as Nelpa Lifesciences Inc in the Philippines ($10.59M) and Generics & Specialities LDA in Mozambique ($2.80M) serve as intermediaries, supplying Erythromycin to various healthcare providers. Their purchasing patterns are influenced by market demand and inventory turnover rates, often resulting in regular, moderate-sized orders.

3. Hospital Groups and Healthcare Providers: Organizations like Ace Health Care LDA in Mozambique ($1.25M) and SBR Group of Companies in Liberia ($1.05M) procure Erythromycin directly for patient care. Their procurement is typically based on patient needs and treatment protocols, leading to variable order sizes and frequencies.

4. Contract Manufacturers and Re-exporters: Entities such as Mylan Australia Pty Limited ($1.07M) and Viatris New Zealand ($0.90M) may import Erythromycin for further processing or distribution. Their purchasing behavior is often characterized by bulk orders aligned with production schedules and market demands.

Overall, the repeat buyer rate of 45.9% indicates a substantial proportion of consistent demand, particularly from government agencies and established distributors, underscoring the importance of maintaining strong relationships with these segments.

For the top five importing countries, the import regulations for Erythromycin are as follows:

The demand for Erythromycin in importing countries is driven by several factors:

1. Disease Prevalence: Erythromycin is widely used to treat respiratory tract infections, skin infections, and other bacterial infections prevalent in many developing countries. The high incidence of such diseases necessitates a steady supply of effective antibiotics.

2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the WHO's Essential Medicines List, which includes Erythromycin, guides national procurement strategies to ensure the availability of critical medications.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased public sector procurement of essential medicines, including antibiotics like Erythromycin, to meet the healthcare needs of the population.

4. Tender-Based Purchasing: Government and international organizations often utilize tender systems to procure large quantities of medicines at competitive prices. This approach ensures a consistent demand for Erythromycin, as evidenced by the significant purchases by entities such as UNICEF and national medical stores.

With 992 buyers across 135 countries, the global market for Erythromycin presents substantial opportunities. The consistent demand from government agencies and healthcare providers underscores the importance of maintaining robust supply chains and compliance with international quality standards to capitalize on these market dynamics.

The importers of Erythromycin from India can be categorized into several key segments:

1. Government Procurement Agencies: Entities like UNICEF Kabul in Afghanistan ($22.63M) and the Medical Stores Department in Tanzania ($1.14M) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply public health programs, ensuring consistent demand and sizable order volumes.

2. Pharmaceutical Distributors: Companies such as Nelpa Lifesciences Inc in the Philippines ($10.59M) and Generics & Specialities LDA in Mozambique ($2.80M) serve as intermediaries, supplying Erythromycin to various healthcare providers. Their purchasing patterns are influenced by market demand and inventory turnover rates, often resulting in regular, moderate-sized orders.

3. Hospital Groups and Healthcare Providers: Organizations like Ace Health Care LDA in Mozambique ($1.25M) and SBR Group of Companies in Liberia ($1.05M) procure Erythromycin directly for patient care. Their procurement is typically based on patient needs and treatment protocols, leading to variable order sizes and frequencies.

4. Contract Manufacturers and Re-exporters: Entities such as Mylan Australia Pty Limited ($1.07M) and Viatris New Zealand ($0.90M) may import Erythromycin for further processing or distribution. Their purchasing behavior is often characterized by bulk orders aligned with production schedules and market demands.

Overall, the repeat buyer rate of 45.9% indicates a substantial proportion of consistent demand, particularly from government agencies and established distributors, underscoring the importance of maintaining strong relationships with these segments.

For the top five importing countries, the import regulations for Erythromycin are as follows:

The demand for Erythromycin in importing countries is driven by several factors:

1. Disease Prevalence: Erythromycin is widely used to treat respiratory tract infections, skin infections, and other bacterial infections prevalent in many developing countries. The high incidence of such diseases necessitates a steady supply of effective antibiotics.

2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the WHO's Essential Medicines List, which includes Erythromycin, guides national procurement strategies to ensure the availability of critical medications.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased public sector procurement of essential medicines, including antibiotics like Erythromycin, to meet the healthcare needs of the population.

4. Tender-Based Purchasing: Government and international organizations often utilize tender systems to procure large quantities of medicines at competitive prices. This approach ensures a consistent demand for Erythromycin, as evidenced by the significant purchases by entities such as UNICEF and national medical stores.

With 992 buyers across 135 countries, the global market for Erythromycin presents substantial opportunities. The consistent demand from government agencies and healthcare providers underscores the importance of maintaining robust supply chains and compliance with international quality standards to capitalize on these market dynamics.